Task: Answer Verification
Input (English): Question: Does a single supratherapeutic dose of ridaforolimus prolong the QTc interval in patients with advanced cancer?
Answer: Administration of the single 100-mg dose of ridaforolimus did not cause a clinically meaningful prolongation of QTcF, suggesting that patients treated with ridaforolimus have a low likelihood of delayed ventricular repolarization.
Output (English): no